abstract |
Disclosed herein are methods and compositions for modulation of telomere length in cells. Aspects are directed to reduction in telomere shortening rate, stabilization of telomere shortening, and/or telomere elongation using fibroblasts or fibroblast-derived products. In some cases, provided are methods for treatment of telomere-associated conditions using fibroblasts or fibroblast-derived products. Fibroblasts may be provided to modulate telomere length in cells of a subject, thereby treating a telomere-associated condition such as, for example, cancer, aging, or idiopathic pulmonary fibrosis. |